Aurora Cannabis (TSE:ACB) Trading Down 0.5% – Here’s What Happened

Posted by Grant Hamersma on Oct 19th, 2024

Aurora Cannabis Inc. (TSE:ACB – Get Free Report)’s share price fell 0.5% during mid-day trading on Thursday . The company traded as low as C$7.54 and last traded at C$7.60. 198,873 shares traded hands during mid-day trading, a decline of 82% from the average session volume of 1,097,400 shares. The stock had previously closed at C$7.64.

Analyst Ratings Changes

Separately, ATB Capital dropped their target price on shares of Aurora Cannabis from C$12.50 to C$11.00 and set a “sector perform” rating for the company in a report on Friday, June 21st.

Get Our Latest Stock Analysis on ACB

Aurora Cannabis Stock Performance

The company has a current ratio of 3.76, a quick ratio of 2.48 and a debt-to-equity ratio of 16.95. The stock’s 50 day moving average price is C$7.99 and its two-hundred day moving average price is C$8.29. The firm has a market capitalization of C$423.62 million, a PE ratio of -12.30 and a beta of 2.71.

Aurora Cannabis (TSE:ACB – Get Free Report) last issued its quarterly earnings data on Wednesday, August 7th. The company reported C($0.16) earnings per share for the quarter, topping analysts’ consensus estimates of C($0.48) by C$0.32. Aurora Cannabis had a negative net margin of 11.53% and a negative return on equity of 6.13%. The business had revenue of C$92.04 million during the quarter, compared to analysts’ expectations of C$76.70 million. On average, equities analysts expect that Aurora Cannabis Inc. will post -0.22 earnings per share for the current year.

Insider Buying and Selling at Aurora Cannabis

In related news, Senior Officer Andre Jerome sold 7,712 shares of Aurora Cannabis stock in a transaction on Monday, September 23rd. The shares were sold at an average price of C$7.70, for a total transaction of C$59,382.40.

Aurora Cannabis Company Profile

(Get Free Report)

Aurora Cannabis Inc, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products.